Biorevert Pipeline
| Drug | Indication | Phase |
|---|
| BRVT101 | Hepatocellular carcinoma | Preclinical |
| BRVT121 | Hepatocellular carcinoma | Phase I |
| BRVT151 | Hepatocellular carcinoma | Phase I |
| BRVT221 | Non‑small‑cell lung cancer (I/O) | Preclinical |
| BRVT321 | Colorectal cancer | Preclinical |
| BRVT301 | Colorectal cancer | Preclinical |